Verition Fund Management
ELV icon

Verition Fund Management’s Elevance Health ELV Stock Holding History

Verition Fund Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-700
Closed -$379K – 3270
2024
Q2 		$379K Buy
+700
New +$370K ﹤0.01% 2211
2023
Q1 		– Sell
-2,500
Closed -$1.28M – 2250
2022
Q4 		$1.28M Hold
2,500
– – 0.02% 809
2022
Q3 		$1.14M Buy
+2,500
New +$1.2M 0.01% 1294
2022
Q2 		– Sell
-2,900
Closed -$1.42M – 2546
2022
Q1 		$1.42M Buy
2,900
+2,200
+314% +$1.01M 0.02% 1222
2021
Q4 		$324K Buy
+700
New +$294K ﹤0.01% 1942

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Verition Fund Management's ELV Position: Q1 2026 in Review

Verition Fund Management increased its Elevance Health (ELV) stake by 1,637% in Q1 2026, buying an estimated $3.9M and bringing the position to 12,607 shares worth $3.69M. The position accounts for 0.02% of the portfolio, ranked #706.

Verition Fund Management first reported a position in ELV in Q3 2013 and has held it in 46 quarters since. The position peaked at $73.7M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Verition Fund Management held 12,607 shares of Elevance Health worth $3.69M as of Q1 2026.
  • Verition Fund Management bought 11,881 Elevance Health shares in Q1 2026, an estimated $3.9M.
  • Elevance Health made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #706 holding.
  • Verition Fund Management first reported a position in Elevance Health in Q3 2013 and has held it in 46 quarters since.
  • Verition Fund Management's Elevance Health position peaked at $73.7M in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.